Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

WSE/BCX stock hub

WSE/BCX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/BCXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

414.6M

Warsaw Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

WSE/BCX

In the news

Latest news · WSE/BCX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-43.2

P25 n/aP50 n/aP75 n/a

ROIC-26.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/BCX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

PLN

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	41
Employees Change	14%
Employees Change Percent	51.85
Enterprise value	PLN 391.1M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology
Isin	PLBCLTX00019
Last refreshed	2026-05-10
Market cap	PLN 414.6M
Price	PLN 84.2
Price currency	PLN
Sector	Healthcare
Sic	2836
Symbol	wse/BCX
Website	https://bioceltix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.57%
EV Earnings	-26.45x
EV/FCF	-29.79x
FCF yield	-3.17%
P/B ratio	15.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	PLN -1.8M
Net Income	PLN -14.8M
Net Income Growth Years	0%
Profit Per Employee	PLN -360,688
ROA	-25.14
ROCE	-55.15
ROE	-43.22
ROIC	-26.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.85%
Cagr3y	7.17%
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	PLN 30.2M
Cash	PLN 24M
Current Assets	PLN 26.2M
Current Liabilities	PLN 3M
Debt	PLN 405,023
Debt Equity	PLN 0.02
Debt FCF	PLN -0.03
Equity	PLN 27M
Interest Coverage	-80.18
Liabilities	PLN 3.2M
Long Term Assets	PLN 3.9M
Long Term Liabilities	PLN 192,842
Net Cash	PLN 23.5M
Net Cash By Market Cap	PLN 5.68
Net Cash Growth	-36.8%
Net Debt Equity	PLN -0.87
Tangible Book Value	PLN 27M
Tangible Book Value Per Share	PLN 5.48
WACC	9.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.83
Inventory Turnover	84.1
Net Working Capital	PLN -399,963
Quick ratio	8.51
Working Capital	PLN 23.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.83%
200-day SMA	90
3Y total return	23.1%
50-day SMA	80.43
50-day SMA vs 200-day SMA	50under200
All Time High	129
All Time High Change	-34.73%
All Time High Date	2025-04-30
All Time Low	28.7
All Time Low Change	193.38%
All Time Low Date	2022-11-08
ATR	3.13
Beta	1.01
Beta1y	0.12
Beta2y	-0.03
Ch YTD	8.51
High	84.3
High52	123
High52 Date	2025-05-08
High52ch	-31.54%
Low	81.5
Low52	70
Low52 Date	2026-03-23
Low52ch	20.29%
Ma50ch	4.69%
Price vs 200-day SMA	-6.45%
RSI	52.12
RSI Monthly	50.05
RSI Weekly	49.12
Sharpe ratio	-0.93x
Sortino ratio	-1.2
Total Return	-25.36%
Tr YTD	8.51
Tr1m	-1.52%
Tr1w	-3.22%
Tr3m	0.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN -15M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,830,920%
Net Borrowing	-967,420
Shares Insiders	7.43%
Shares Institutions	25.27%
Shares Out	4,924,468
Shares Qo Q	0%
Shares Yo Y	25.36%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN -13.1M
Average Volume	6,209.85x
Bv Per Share	5.48
CAPEX	PLN -1.6M
Ch1m	-1.52
Ch1w	-3.22
Ch1y	-29.83
Ch3m	0.72
Ch3y	23.1
Ch6m	-13.11
Change	0.36%
Change From Open	0.48
Close	83.9
Days Gap	-0.12
Depreciation Amortization	727,693
Dollar Volume	211,763
Earnings Date	2026-04-28
EBIT	PLN -15M
EBITDA	PLN -14.3M
EPS	PLN -2.89
F Score	1
FCF	PLN -13.1M
FCF EV Yield	-3.36x
FCF Per Share	PLN -2.67
Financing CF	-1,154,475
Fiscal Year End	December
Founded	2,016
Income Tax	PLN -51,492
Investing CF	-1,604,351
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2025-09-30
Ma150	85.9
Ma150ch	-1.98%
Ma20	84.28
Ma20ch	-0.09%
Net CF	-14,248,463
Next Earnings Date	2026-05-29
Open	83.8
Position In Range	96.43
Ppne	3,527,771
Price Date	2026-05-08
Ptbv Ratio	15.35
Relative Volume	0.41x
Tr6m	-13.11%
Volume	2,515

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WSE/BCX pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/BCX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/BCX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.3%

Share of float held by funds and institutions

Insider ownership

+7.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+25.4%

Negative means the company is buying back shares.

Technical

WSE/BCX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.1

Neutral momentum band

Price vs 200-day MA

-6.4%

50/200-day relationship not available

Beta (5Y)

1.01

Moves roughly with the market

Sharpe ratio

-0.93

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/BCX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/BCX stock rating?

wse/BCX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/BCX analysis?

The full report lives at /stocks/wse/BCX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/BCX?

The latest report frames wse/BCX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/BCX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.